Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
Enric I.
Canela Campos
Publications by the researcher in collaboration with Enric I. Canela Campos (7)
2018
-
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Brain, Behavior, and Immunity, Vol. 67, pp. 139-151
2017
-
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors
Frontiers in Pharmacology, Vol. 8, Núm. OCT
2015
-
Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia
Molecular Neurobiology, Vol. 52, Núm. 3, pp. 1408-1420
2014
-
L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
Experimental Neurology, Vol. 253, pp. 180-191
-
L-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus
Neuropharmacology, Vol. 79, pp. 90-100
2012
-
Cannabinoid receptors CB 1 and CB 2 form functional heteromers in brain
Journal of Biological Chemistry, Vol. 287, Núm. 25, pp. 20851-20865
2009
-
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors
Journal of Biological Chemistry, Vol. 284, Núm. 41, pp. 28058-28068